| Date | Title | | | May. 23, 2013 | Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference| BRAINTREE, Mass., May 23, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO & EVP-Business Development, will present at The Deutsche Bank 38th Annual dbAccess Health Care Conference in Boston, MA on May 29, 2013 at 1:30pm Eastern time.
(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )
The public may access Mr. Lindop's presentation live via webcast at: http://www.media-server.com/m/p/je7nwq7n
About Haemonetics
Haemoneti... |
|  | | May. 01, 2013 | Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidance| BRAINTREE, Mass., May 1, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported fourth quarter fiscal 2013 net revenue of $249.9 million, up 34%, GAAP net income of $12.6 million, down 29%, and diluted earnings per share of $0.24, down 31%. Adjusted net income, exclusive of restructuring, integration and other costs detailed below, was $25.1million, up 21%, and adjusted earnings per share were $0.48, up 19%. Excluding currency impact, net revenue was up 38% in the qu... |
| | | May. 01, 2013 | Haemonetics Completes Hemerus Medical, LLC Acquisition| BRAINTREE, Mass., May 1, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) today announced that it has completed its previously announced acquisition of the assets of Hemerus Medical, LLC ("Hemerus"), a Minnesota-based company that develops innovative technologies for the collection of whole blood and for the processing and storage of blood components.
(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )
Haemonetics recently learned that the U.S. FDA approved Hemerus' N... |
| | | Apr. 24, 2013 | Haemonetics Sets Date for Investor/Analyst Meeting| BRAINTREE, Mass., April 24, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst meeting on Thursday, May 16th from 10:00 am to 3:00 pm at The Seaport Hotel in Boston, Massachusetts.
(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO)
The agenda for the meeting includes updates on the following:
Hospital Based Blood Management Solutions / Emerging Markets
R&D Update Including Automated Whole Blood, ... |
| | | Apr. 01, 2013 | Haemonetics Sets Date for Fourth Quarter Fiscal Year 2013 Earnings Release: Wednesday, May 1, 2013| BRAINTREE, Mass., April 1, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) will announce its earnings for the fourth quarter and full fiscal year 2013 and will provide guidance for fiscal year 2014 on Wednesday, May 1, 2013 in a pre-market press release. The Company will hold a webcast to discuss and answer questions about the press release at 8:00 am (EDT) on May 1, 2013.
(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )
Webcast Link: http://phx.corporate-ir.net/p... |
| | | Feb. 25, 2013 | Haemonetics to Present at The Raymond James Institutional Investors Conference|
BRAINTREE, Mass., Feb. 25, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at The Raymond James Institutional Investors Conference in Orlando, Florida on March 6, 2013 at 8:40am Eastern time.
(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO)
The public may access Mr. Concannon's presentation live via webcast at http://wsw.com/webcast/rj82/hae/.
About Haemonetics
Haemonetics (NYSE: HAE) ... |
| | | Feb. 14, 2013 | Haemonetics' CMO, Mark Popovsky, Joins U.S. Health and Human Services Advisory Committee on Blood Safety|
BRAINTREE, Mass., Feb. 14, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that Vice President and Chief Medical Officer, Dr. Mark A. Popovsky, has been invited by the U.S. Department of Health & Human Services Secretary Kathleen Sebelius, to serve on the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA).
(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )
As one of nine official representative members of the blood, blood ... |
| | | Feb. 13, 2013 | Haemonetics to Present at Citi 2013 Global Healthcare Conference|
BRAINTREE, Mass., Feb. 13, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the Citi 2013 Global Healthcare Conference in New York on February 26, 2013 at 1:30pm Eastern time.
(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )
The public may access Mr. Concannon's presentation live via webcast at http://www.veracast.com/webcasts/citigroup/healthcare2013/25208346.cfm
About Haemonetics
... |
| | | Feb. 06, 2013 | Haemonetics to Present at Leerink Swann 2013 Global Healthcare Conference|
BRAINTREE, Mass., Feb. 6, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO and VP, Business Development, will present at the Leerink Swann 2013 Global Healthcare Conference in New York on February 13, 2013 at 3:00pm Eastern time.
The public may access Mr. Lindop's presentation live via webcast at http://leerink.metameetings.com/webcasts/healthcare13/directlink?p=167.
(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )
Abou... |
| | | Jan. 30, 2013 | Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70|
BRAINTREE, Mass., Jan. 30, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported third quarter 2013 net revenue of $247.4 million, up 29%, GAAP net income of $9.9 million, down 46%, and diluted earnings per share of $0.19, down 47%. Adjusted net income, exclusive of restructuring and other costs detailed below, was $26.4 million, up 20%, and adjusted earnings per share were $0.50, up 16%.1
(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )
Organic net rev... |
| | | Jan. 09, 2013 | Haemonetics Sets Date for Third Quarter Fiscal Year 2013 Earnings Release: January 30, 2013|
BRAINTREE, Mass., Jan. 9, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) will announce its earnings for the third quarter of its fiscal year 2013 on January 30, 2013 in a pre-market press release. The Company will hold a webcast to discuss and answer questions about the press release at 8:00 am (EST) on January 30, 2013.
(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )
Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118... |
| | | Jan. 04, 2013 | Haemonetics to Provide an Update on Key Growth Initiatives at J.P. Morgan Health Care Conference|
BRAINTREE, Mass., Jan. 4, 2013 /PRNewswire/ --
Whole Blood Acquisition Integration Ahead of Schedule
Paperless Phlebotomy On Track For Limited Market Release in Q4 Fiscal 2013
OrthoPAT® Advance™ Receives 510K Approval
Emerging Market Investments Driving Growth in TEG® and Cell Salvage
Customer Adoption of Blood Management Solutions Driving Hospital Growth
Hemerus Medical Remains on Track To Respond To FDA's SOLX® Questions
Haemonetics Corporation (NYSE: HAE) today announ... |
| |
|
